United Therapeutics Stock Options
| UTHR Stock | USD 358.93 7.46 2.04% |
United Therapeutics' latest option contracts expiring on March 21st 2025 are carrying combined implied volatility of 0.44. The United Therapeutics option chain provides detailed quote and price information for the current United Therapeutics option contracts. It shows all of United Therapeutics' listed puts, calls, expiration dates, strike prices, and other pricing information.
In The Money vs. Out of Money Option Contracts on United Therapeutics
Analyzing United Therapeutics' in-the-money options over time can help investors to take a profitable long position in United Therapeutics regardless of its overall volatility. This is especially true when United Therapeutics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money United Therapeutics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with United Therapeutics' stock while costing only a fraction of its price.
United Current Options Market Mood
United Therapeutics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps United Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Volume
Most options investors, including buyers and sellers of United Therapeutics' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. United Therapeutics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current United contract
Base on the Rule 16, the options market is currently suggesting that United Therapeutics will have an average daily up or down price movement of about 0.0275% per day over the life of the 2025-03-21 option contract. With United Therapeutics trading at USD 358.93, that is roughly USD 0.0987. If you think that the market is fully incorporating United Therapeutics' daily price movement you should consider buying United Therapeutics options at the current volatility level of 0.44%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
United |
Purchasing United Therapeutics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" United calls. Remember, the seller must deliver United Therapeutics stock to the call owner when a call is exercised.
United Therapeutics Option Chain
When United Therapeutics' strike price is surpassing the current stock price, the option contract against United Therapeutics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
United Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on United. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for United. It also shows strike prices and maturity days for a United Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | UTHR250321C00380000 | 91 | 380.0 | 6.0 - 15.7 | 13.3 | Out |
Call | UTHR250321C00430000 | 0 | 430.0 | 0.1 - 10.0 | 0.1 | |
Call | UTHR250321C00440000 | 1 | 440.0 | 0.1 - 10.0 | 3.5 | Out |
Call | UTHR250321C00450000 | 1 | 450.0 | 0.05 - 10.0 | 3.2 | Out |
Call | UTHR250321C00460000 | 0 | 460.0 | 0.0 - 4.8 | 4.8 | |
Call | UTHR250321C00470000 | 0 | 470.0 | 0.0 - 4.8 | 1.8 | |
Call | UTHR250321C00480000 | 0 | 480.0 | 0.0 - 4.8 | 4.8 | |
Call | UTHR250321C00490000 | 0 | 490.0 | 0.0 - 4.8 | 4.8 | |
Call | UTHR250321C00500000 | 0 | 500.0 | 0.0 - 4.8 | 4.8 | |
Call | UTHR250321C00520000 | 0 | 520.0 | 0.1 - 10.0 | 0.1 | |
Call | UTHR250321C00540000 | 0 | 540.0 | 0.0 - 4.8 | 0.5 | |
Put | UTHR250321P00430000 | 0 | 430.0 | 66.1 - 76.0 | 66.1 | In |
Put | UTHR250321P00440000 | 0 | 440.0 | 76.2 - 86.0 | 76.2 | In |
Put | UTHR250321P00450000 | 0 | 450.0 | 86.2 - 96.0 | 86.2 | In |
Put | UTHR250321P00460000 | 0 | 460.0 | 96.2 - 106.0 | 96.2 | In |
Put | UTHR250321P00470000 | 0 | 470.0 | 106.2 - 116.0 | 106.2 | In |
Put | UTHR250321P00480000 | 0 | 480.0 | 116.2 - 126.0 | 116.2 | In |
Put | UTHR250321P00490000 | 0 | 490.0 | 126.2 - 136.0 | 126.2 | In |
Put | UTHR250321P00500000 | 0 | 500.0 | 136.2 - 146.0 | 136.2 | In |
Put | UTHR250321P00520000 | 0 | 520.0 | 156.2 - 166.0 | 156.2 | In |
Put | UTHR250321P00540000 | 0 | 540.0 | 176.2 - 186.0 | 176.2 | In |
United Therapeutics Selling And Marketing Expenses Over Time
Selling And Marketing Expenses |
| Timeline |
United Therapeutics Market Cap Over Time
Market Cap |
| Timeline |
United Total Stockholder Equity
Total Stockholder Equity |
|
United Therapeutics Corporate Management
| Holly Hobson | Associate Resources | Profile | |
| JD MBA | Chairman Founder | Profile | |
| Gil Golden | Senior Officer | Profile | |
| Dewey CFA | Head Relations | Profile | |
| Kevin Gray | Senior Logistics | Profile |
Additional Tools for United Stock Analysis
When running United Therapeutics' price analysis, check to measure United Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy United Therapeutics is operating at the current time. Most of United Therapeutics' value examination focuses on studying past and present price action to predict the probability of United Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move United Therapeutics' price. Additionally, you may evaluate how the addition of United Therapeutics to your portfolios can decrease your overall portfolio volatility.